M. Juneau-Norcross

A Prospective, Randomized Trial of Gonadotropin‐Releasing Hormone Agonist Plus Estrogen‐Progestin or Progestin “Add‐Back” Regimens for Women With Leiomyomata Uteri

R. Gleason, R. Gleason, M. LeBoff, 1993, The Journal of clinical endocrinology and metabolism.

Recurrence of myomas after myomectomy in women pretreated with leuprolide acetate depot or placebo.

M. Daly, A. Friedman, M. Rein, 1992, Fertility and sterility.

A Prospective, Randomized Trial of Gonadotropin-Releasing Hormone Agonist Plus Estrogen-Progestin or Progestin “Add-Back” Regimens for Women With Leiomyomata Uteri

R. Gleason, M. LeBoff, M. Daly, 1994 .

Adverse effects of leuprolide acetate depot treatment.

A. Friedman, M. Rein, M. Juneau-Norcross, 1993, Fertility and sterility.

Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.

R. Gleason, M. LeBoff, M. Daly, 1994, Human reproduction.

Antisperm antibody production following intrauterine insemination.

A. Friedman, M. Juneau-Norcross, B. Sedensky, 1991, Human reproduction.

Life table analysis of intrauterine insemination pregnancy rates for couples with cervical factor, male factor, and idiopathic infertility.

D. Cramer, N. Andrews, A. Friedman, 1991, Fertility and sterility.

Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.

M. Daly, A. Friedman, M. Rein, 1992, Fertility and sterility.